Both in Biotechnology
Passage Bio vs TScan Therapeutics
Over the past year PASG returned −47.1% and TCRX returned −81.3%; their daily moves had a correlation of 0.06.
PASG −47.1% TCRX −81.3%Growth of $1, one year, split-adjusted
| Metric | PASG | TCRX |
|---|---|---|
| Price | $3.51 | $0.2100 |
| Market cap | $11.3M | $14.2M |
| Today | +3.24% | +11.11% |
| 1 month | −14.0% | −23.7% |
| 6 months | −14.8% | −83.2% |
| Year to date | −70.3% | −79.0% |
| 1 year | −52.0% | −83.1% |
| Revenue growth (YoY) | — | −65.8% |
| Gross margin | — | 100.0% |
| Net margin | — | −2888.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 2.0× |
| Net cash | $24.2M | $67.4M |
| Dividend yield | — | — |
| Volatility (60d) | 77.3% | 143.0% |
| Short % of float | 2.4% | 4.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).